Wird geladen...
Buprenorphine for managing opioid withdrawal
BACKGROUND: Managed withdrawal is a necessary step prior to drug‐free treatment or as the endpoint of substitution treatment. OBJECTIVES: To assess the effects of buprenorphine versus tapered doses of methadone, alpha(2)‐adrenergic agonists, symptomatic medications or placebo, or different buprenorp...
Gespeichert in:
| Veröffentlicht in: | Cochrane Database Syst Rev |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley & Sons, Ltd
2017
|
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6464315/ https://ncbi.nlm.nih.gov/pubmed/28220474 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD002025.pub5 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|